ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
항체 발굴 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년 연평균 성장률(CAGR)은 10.0%를 나타낼 것으로 예측되고 143억 1,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 항체 신약 개발 서비스 및 플랫폼에 대한 수요 증가, 신기술 개발을 위한 자금 급증, 정밀 치료제 수요 증가, 그리고 항체의 기존 치료 역할 외의 확장되는 활용 범위에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 연구 개발 활동 증가, 단일클론 항체 수요 증가, 고급 기술 채택 증가, 표적 치료제 수요 증가, 그리고 새로운 항체 형식의 개발 등이 있습니다.
향후 5년간 10.0% 성장률 전망은 해당 시장에 대한 이전 추정치 대비 0.3% 소폭 하향 조정된 수치입니다. 이 같은 하향 조정은 주로 미국과 타국 간 관세 영향에 기인합니다. 관세 장벽은 스웨덴 및 싱가포르에서 원해 파지 디스플레이 및 단일 B세포 스크리닝 플랫폼의 비용을 증가시켜 미국 바이오테크 혁신을 저해할 것으로 예상되며, 이는 치료용 항체 개발 지연과 의약품 개발 비용 상승으로 이어질 것입니다. 상호 보복 관세와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 효과는 더욱 광범위하게 나타날 것입니다.
정밀 치료제(개인 맞춤형 치료제)에 대한 수요 증가로 항체 발굴 시장은 상당한 성장을 앞두고 있습니다. 이 접근법은 개별 환자 특성에 맞춰 의료 치료를 설계하여 효과를 높입니다. 항체 발굴은 단일클론 항체와 같은 표적 치료제 개발을 촉진함으로써 정밀 치료에서 중추적 역할을 수행합니다. 이러한 항체는 질병 관련 분자나 세포와 정확히 상호작용합니다. 특히 2023년 1월, 미국 식품의약국(FDA) 산하 의약품평가연구센터(CDER)는 37개의 신약주체(NME)를 승인했으며, 치료용 NME의 약 34%가 맞춤형 의약품으로 분류되었습니다. 이는 항체 발굴 시장을 촉진하는 정밀 치료 시장의 중추적 역할을 강조합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 항체 발굴 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 항체 발굴 시장 : 성장률 분석
세계의 항체 발굴 시장 실적 : 규모와 성장(2019-2024년)
세계의 항체 발굴 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 항체 발굴 : 총 잠재시장 규모(TAM)
제6장 시장 세분화
세계의 항체 발굴 시장 : 방법별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
파지 디스플레이
하이브리도마
기타 방법
세계의 항체 발굴 시장 : 항체 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
인간화 항체
인간 항체
키메라 항체
마우스 항체
세계의 항체 발굴 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제약 및 생명공학 산업
연구실
학술연구실
세계의 항체 발굴 시장, 파지 디스플레이 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 항체 발굴 시장, 기타 방법 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
트랜스제닉 마우스 기술
B세포 공학
단일 세포 선별 기술
제7장 지역별, 국가별 분석
세계의 항체 발굴 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 항체 발굴 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
항체 발굴 시장 : 경쟁 구도
항체 발굴 시장 : 기업 프로파일
Danaher Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Eurofins Scientific : 개요, 제품 및 서비스, 전략 및 재무 분석
Sartorius AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Charles River Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
Bruker Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
WuXi Biologics
Genmab A/S
Evotec
Cambrex corporation
ChemPartner
Aragen life science pvt ltd
Genscript Technology Corporation
Biocytogen
Alcami corporation.Inc
Twist Bioscience
BioDuro-Sundia
Fairjourney Biologics SA
Harbour BioMed
Rockland Immunochemicals
Creative Biolabs
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
항체 발굴 시장(2029년) : 새로운 기회를 제공하는 국가
항체 발굴 시장(2029년) : 새로운 기회를 제공하는 부문
항체 발굴 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Antibody discovery is the process of identifying and developing antibodies, which are proteins generated by the immune system to defend the body against harmful substances such as bacteria and viruses. Antibodies, also known as immunoglobulins, play a vital role in the immune response by recognizing and binding to specific molecules known as antigens.
The primary methods employed in antibody discovery include phage display, hybridoma, and others. Phage display is a molecular biology technique utilized for the study and selection of peptides or proteins, typically antibodies, that exhibit high affinity to a target of interest. This method is widely applied in antibody discovery to generate and select antibodies with specific binding properties. Various types of antibodies, including humanized antibodies, human antibodies, chimeric antibodies, and murine antibodies, find application among end users in the pharmaceutical and biotechnology industries, research laboratories, and academic institutions.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.
The antibody discovery research report is one of a series of new reports from The Business Research Company that provides antibody discovery market statistics, including the antibody discovery industry's global market size, regional shares, competitors with an Antibody discovery market share, detailed antibody discovery market segments, market trends and opportunities, and any further data you may need to thrive in the antibody discovery industry. This antibody discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The antibody discovery market size has grown strongly in recent years. It will grow from $8.96 billion in 2024 to $9.78 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to surge in investment for drug discovery, growing investment in research and development activities, and presence of various healthcare research centers and academic institutions.
The antibody discovery market size is expected to see strong growth in the next few years. It will grow to $14.31 billion in 2029 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing demand for antibody drug discovery services and platforms, surge in funding for the development of novel technologies, growing demand for precision therapeutics, and broadening the utilization of antibodies beyond their conventional therapeutic roles. Major trends in the forecast period include increased research and development activities, growing demand for monoclonal antibodies, increased adoption of advanced technologies, growing demand for targeted therapeutics, and development of novel antibody formats.
The forecast of 10.0% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. biotech innovation by increasing the cost of phage display and single B-cell screening platforms sourced from Sweden and Singapore, thereby delaying therapeutic antibody development and elevating drug discovery costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The antibody discovery market is poised for significant growth due to the increasing demand for precision therapeutics, also known as personalized therapeutics. This approach tailors medical treatments to individual patient characteristics, enhancing effectiveness. Antibody discovery plays a pivotal role in precision therapeutics by facilitating the development of targeted therapies such as monoclonal antibodies, which interact precisely with disease-related molecules or cells. Notably, in January 2023, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% of therapeutic NMEs classified as personalized medicines. This underscores the pivotal role of precision therapeutics in driving the antibody discovery market's growth.
Leading players in the antibody discovery market are investing in cutting-edge technologies to streamline and enhance antibody development processes. One notable innovation is the emergence of AI-based computational antibody drug discovery platforms, which leverage artificial intelligence and computational techniques to expedite antibody identification and optimization. For example, in October 2023, SwiftPharma BV introduced an AI-driven antibody discovery platform. This platform integrates artificial intelligence, big data, machine learning, and phage display techniques to swiftly predict high-specificity and high-affinity antibody-antigen binding. By mimicking natural language processing, this approach generates diverse antibody variations, enabling comprehensive antibody library creation with unprecedented efficiency. This advanced system significantly accelerates the discovery of potential antibody drugs.
In July 2024, Pentixapharm, a Germany-based biotech company specializing in radiopharmaceuticals, acquired Glycotope's target discovery unit for an undisclosed sum. This acquisition supports Pentixapharm's strategy to enhance its oncology pipeline by converting preclinical antibodies targeting various cancer indications into radiopharmaceuticals. In addition to the preclinical assets, Pentixapharm acquired Glycotope's laboratories, cell banks, tumor target database, and equipment, thereby further enriching its Intellectual Property portfolio beyond the CXCR4 receptor. Glycotope, also based in Germany, is a biotechnology firm focused on developing glyco-optimized antibodies for cancer immunotherapies.
Major companies operating in the antibody discovery market report are Danaher Corporation, Eurofins Scientific, Sartorius AG, Charles River Laboratories, Bruker Corporation, WuXi Biologics, Genmab A/S, Evotec, Cambrex corporation, ChemPartner, Aragen life science Pvt ltd, Genscript Technology Corporation, Biocytogen, Alcami Corporation Inc, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A, Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico
North America was the largest region in the antibody discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the antibody discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The antibody discovery market includes revenues earned by entities by providing services such as antigen identification, immunization, antibody generation, screening, and characterization. The market value includes the value of related goods sold by the service provider or included within the service offering. The antibody discovery market also includes sales of antibody libraries, phage display kits, antigen proteins, and antibody screening platforms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Antibody Discovery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on antibody discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for antibody discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The antibody discovery market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Methods: Phage Display; Hybridoma; Other Methods
2) By Antibody Type: Humanized Antibody; Human Antibody; Chimeric Antibody; Murine Antibody
3) By End Users: Pharmaceutical And Biotechnology Industry; Research Laboratory; Academic Laboratory
Subsegments:
1) By Phage Display: Selection And Screening Techniques; Optimization Methods
2) By Hybridoma: Monoclonal Antibody Production; Screening And Selection Processes
3) By Other Methods: Transgenic Mouse Technology; B-Cell Engineering; Single-Cell Sorting Techniques
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Antibody Discovery Market Characteristics
3. Antibody Discovery Market Trends And Strategies
4. Antibody Discovery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Antibody Discovery Growth Analysis And Strategic Analysis Framework
5.1. Global Antibody Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Antibody Discovery Market Growth Rate Analysis
5.4. Global Antibody Discovery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Antibody Discovery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Antibody Discovery Total Addressable Market (TAM)
6. Antibody Discovery Market Segmentation
6.1. Global Antibody Discovery Market, Segmentation By Methods, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Phage Display
Hybridoma
Other Methods
6.2. Global Antibody Discovery Market, Segmentation By Antibody Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Humanized Antibody
Human Antibody
Chimeric Antibody
Murine Antibody
6.3. Global Antibody Discovery Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Industry
Research Laboratory
Academic Laboratory
6.4. Global Antibody Discovery Market, Sub-Segmentation Of Phage Display, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Selection And Screening Techniques
Optimization Methods
6.5. Global Antibody Discovery Market, Sub-Segmentation Of Hybridoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibody Production
Screening And Selection Processes
6.6. Global Antibody Discovery Market, Sub-Segmentation Of Other Methods, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Transgenic Mouse Technology
B-Cell Engineering
Single-Cell Sorting Techniques
7. Antibody Discovery Market Regional And Country Analysis
7.1. Global Antibody Discovery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Antibody Discovery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
